MR O’Donnell

1.8k total citations
25 papers, 1.4k citations indexed

About

MR O’Donnell is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, MR O’Donnell has authored 25 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 10 papers in Oncology and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in MR O’Donnell's work include Hematopoietic Stem Cell Transplantation (15 papers), Acute Lymphoblastic Leukemia research (8 papers) and Acute Myeloid Leukemia Research (7 papers). MR O’Donnell is often cited by papers focused on Hematopoietic Stem Cell Transplantation (15 papers), Acute Lymphoblastic Leukemia research (8 papers) and Acute Myeloid Leukemia Research (7 papers). MR O’Donnell collaborates with scholars based in United States. MR O’Donnell's co-authors include GM Schmidt, DS Snyder, Irena Sniecinski, Barbara Nowicki, LR Hill, AP Nademanee, PM Parker, KG Blume, AS Stein and Auayporn Nademanee and has published in prestigious journals such as Blood, Leukemia and Lung Cancer.

In The Last Decade

MR O’Donnell

25 papers receiving 1.4k citations

Peers

MR O’Donnell
Comparison fields: 5 of 72
  • Hematology 982
  • Public Health, Environmental and Occupational Health 405
  • Oncology 358
  • Pathology and Forensic Medicine 234
  • Genetics 208
Replace J P Vernant with:
J P Vernant France
G. L. Phillips Canada
Appelbaum Fr United States
J. W. Andersen United States
Po‐Nan Wang Taiwan
J Cahn France
Nathalie Fegueux France
GE Sale United States
Francesco Nobile Italy
H Demuynck Belgium
J P Vernant France View profile →
Citations per field, relative to MR O’Donnell
MR O’Donnell · 1×
Citations per year, relative to MR O’Donnell
MR O’Donnell · 1×

Countries citing papers authored by MR O’Donnell

Since Specialization
Citations

This map shows the geographic impact of MR O’Donnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MR O’Donnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MR O’Donnell more than expected).

Fields of papers citing papers by MR O’Donnell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MR O’Donnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MR O’Donnell. The network helps show where MR O’Donnell may publish in the future.

Co-authorship network of co-authors of MR O’Donnell

This figure shows the co-authorship network connecting the top 25 collaborators of MR O’Donnell. A scholar is included among the top collaborators of MR O’Donnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MR O’Donnell. MR O’Donnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 22
2 14
3 81
4 140
5 3
6 70
7 91
8 6
9 94
10
Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients.
117
11 243
12 8
13 6
14
Cytarabine, cisplatin, and etoposide chemotherapy for refractory non-Hodgkin's lymphoma.
16
15
A prospective randomized study of acute graft-v-host disease in 107 patients with leukemia: methotrexate/prednisone v cyclosporine A/prednisone.
64
16 139
17 94
18 17
19
High-dose cytosine arabinoside and daunomycin as primary therapy for adults with acute nonlymphoblastic leukemia: a pilot study.
13
20
Small cell cancer of lung; rapid tumor necrosis leading to serious pulmonary infections after intensive chemotherapy.
4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026